These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 18064563)

  • 1. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy.
    Navari RM; Brenner MC; Wilson MN
    Breast Cancer Res Treat; 2008 Nov; 112(1):197-201. PubMed ID: 18064563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group.
    Fisch MJ; Loehrer PJ; Kristeller J; Passik S; Jung SH; Shen J; Arquette MA; Brames MJ; Einhorn LH;
    J Clin Oncol; 2003 May; 21(10):1937-43. PubMed ID: 12743146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.
    Holland JC; Romano SJ; Heiligenstein JH; Tepner RG; Wilson MG
    Psychooncology; 1998; 7(4):291-300. PubMed ID: 9741068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
    Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
    Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
    Muss HB; Tu D; Ingle JN; Martino S; Robert NJ; Pater JL; Whelan TJ; Palmer MJ; Piccart MJ; Shepherd LE; Pritchard KI; He Z; Goss PE
    J Clin Oncol; 2008 Apr; 26(12):1956-64. PubMed ID: 18332474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy.
    Roscoe JA; Morrow GR; Hickok JT; Mustian KM; Griggs JJ; Matteson SE; Bushunow P; Qazi R; Smith B
    Breast Cancer Res Treat; 2005 Feb; 89(3):243-9. PubMed ID: 15754122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer.
    Bardwell WA; Natarajan L; Dimsdale JE; Rock CL; Mortimer JE; Hollenbach K; Pierce JP
    J Clin Oncol; 2006 Jun; 24(16):2420-7. PubMed ID: 16651649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
    Goss PE; Ingle JN; Pater JL; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Tu D
    J Clin Oncol; 2008 Apr; 26(12):1948-55. PubMed ID: 18332475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
    Groenvold M; Fayers PM; Petersen MA; Mouridsen HT
    Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study.
    Payne J; Piper B; Rabinowitz I; Zimmerman B
    Oncol Nurs Forum; 2006 Jul; 33(4):775-83. PubMed ID: 16858459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
    Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer.
    Yates P; Aranda S; Hargraves M; Mirolo B; Clavarino A; McLachlan S; Skerman H
    J Clin Oncol; 2005 Sep; 23(25):6027-36. PubMed ID: 16135471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy.
    Browall MM; Ahlberg KM; Persson LO; Karlsson PO; Danielson EB
    Acta Oncol; 2008; 47(2):207-15. PubMed ID: 18210297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is adjuvant therapy for older patients with node (-) early breast cancer cost-effective?
    Naeim A; Keeler EB
    Crit Rev Oncol Hematol; 2005 Jan; 53(1):81-9. PubMed ID: 15607936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
    Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
    J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional role.
    Hack TF; Pickles T; Ruether JD; Weir L; Bultz BD; Mackey J; Degner LF
    Psychooncology; 2010 Jun; 19(6):606-16. PubMed ID: 19557823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Learned resourcefulness, quality of life, and depressive symptoms for patients with breast cancer.
    Huang CY; Guo SE; Hung CM; Shih SL; Lee LC; Hung GC; Huang SM
    Oncol Nurs Forum; 2010 Jul; 37(4):E280-7. PubMed ID: 20591791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
    Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
    J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk of depressive symptoms 3-4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer.
    Christensen S; Zachariae R; Jensen AB; Vaeth M; Møller S; Ravnsbaek J; von der Maase H
    Breast Cancer Res Treat; 2009 Jan; 113(2):339-55. PubMed ID: 18278553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.